Optimizing Research Studies in Neurological Diseases
Biorasi provides solutions to the challenges facing Parkinson’s Disease Clinical Trials
BIORASI PROVIDES SOLUTIONS TO THE CHALLENGES FACING PARKINSON’S CLINICAL TRIALS
With an estimate of one person out of 37 expected to be diagnosed with Parkinson’s Disease in their lifetime, the need for clinical research in the treatment of neurodegenerative disorders continues to grow. However, executing clinical trials for Parkinson’s does come with its own unique challenges:
- Recruitment and retention for Parkinson’s studies are shifting from more common late stage pathology to rare pre-symptomatic patients.
- Overall participation in clinical studies can be hampered by the degenerative nature of the disease.
- Potential patient subjects may be restricted from traveling to site locations for treatment.
Learn more about the challenges in movement disorder clinical trials.
Removing the Obstacles Facing Parkinson’s Research
As a leading CRO, Biorasi combines our expertise in Parkinson’s and other neurological disorders with an innovative project management strategy to remove challenges to the successful completion of clinical trials.
Biorasi brings leading-edge recruitment and retention solutions that build upon patient-centric strategies and the latest technology. Once the study has started, we ensure patient participation through digital monitoring and wearables, as well as establishing robust communication across all trial stakeholders.
We also leverage a spectrum of decentralized trial options that can both remove the travel burden from your patients and expand the reach of your study on a global scale.